# Melanil in the Treatment of Melasma

> **NCT01001624** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 150 (actual)

## Conditions studied

- Melasma

## Interventions

- **OTHER:** Melanil facial cream
- **OTHER:** Hydroquinone 2% cream

## Key facts

- **NCT ID:** NCT01001624
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001624, "Melanil in the Treatment of Melasma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01001624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*